Thalidomide Enantiomers - Chirality in Pharmacology

What happens with Thalidomide enantiomers?

Thalidomide is a Sedative / Immunomodulator. The R-enantiomer is Effective sedative, while the S-enantiomer is Teratogenic - causes birth defects. The thalidomide disaster of the 1950s-60s showed that enantiomers can have drastically different biological effects. Even pure R-thalidomide racemizes in vivo.

Drug NameThalidomide
Drug ClassSedative / Immunomodulator
R-Enantiomer ActivityEffective sedative
S-Enantiomer ActivityTeratogenic - causes birth defects
FDA StatusWithdrawn, later reapproved with strict controls (REMS) for multiple myeloma and leprosy
Year of Discovery1954
Clinical SignificanceThe thalidomide disaster of the 1950s-60s showed that enantiomers can have drastically different biological effects. Even pure R-thalidomide racemizes in vivo.

Introduction

Thalidomide is perhaps the most infamous example of chirality in medicine. Marketed in the 1950s as a "safe" sedative for pregnant women, it caused thousands of birth defects worldwide.

Structure Comparison

Both enantiomers share the same molecular formula C₁₃H₁₀N₂O₄ and consist of a glutarimide ring connected to a phthalimide ring through a single chiral carbon.

Chiral Center

The chiral center sits at the junction of the two ring systems. It bears four different substituents: the glutarimide ring, the phthalimide nitrogen, a hydrogen, and the methylene bridge.

Pharmacological Differences

R-thalidomide acts as a sedative, binding to cereblon (CRBN) in a way that induces sleep. S-thalidomide also binds cereblon but triggers degradation of transcription factors critical for limb development.

Clinical Impact

Over 10,000 children were born with severe birth defects before thalidomide was withdrawn. This tragedy led directly to the 1962 Kefauver-Harris Amendment requiring proof of drug safety.

Key Takeaway

Even if you could isolate pure R-thalidomide, it rapidly racemizes (converts to a 50/50 mixture) under physiological conditions. This makes it impossible to avoid the toxic S-form in vivo.

Visualize R and S enantiomers side by side with activity indicators and pharmacological profiles.

Compare Thalidomide Enantiomers in 3D

Related Topics